Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Lower By -14.09% This Week?

A rating of 99 puts BioLine RX Ltd - ADR (BLRX) near the top of the Biotechnology industry according to InvestorsObserver. BioLine RX Ltd - ADR's score of 99 means it scores higher than 99% of stocks in the industry. BioLine RX Ltd - ADR also received an overall rating of 84, putting it above 84% of all stocks. Biotechnology is ranked 76 out of the 148 industries.

BLRX has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on BLRX!

See Full BLRX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With BioLine RX Ltd - ADR Stock Today?

BioLine RX Ltd - ADR (BLRX) stock is lower by -8.7% while the S&P 500 is up 0.2% as of 10:07 AM on Thursday, Sep 28. BLRX is lower by -$0.18 from the previous closing price of $2.07 on volume of 411,253 shares. Over the past year the S&P 500 has risen 15.16% while BLRX is up 105.43%. BLRX lost -$0.73 per share the over the last 12 months. Click Here to get the full Stock Report for BioLine RX Ltd - ADR stock.